DE1593782B2 - 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate - Google Patents

1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Info

Publication number
DE1593782B2
DE1593782B2 DE1967B0093025 DEB0093025A DE1593782B2 DE 1593782 B2 DE1593782 B2 DE 1593782B2 DE 1967B0093025 DE1967B0093025 DE 1967B0093025 DE B0093025 A DEB0093025 A DE B0093025A DE 1593782 B2 DE1593782 B2 DE 1593782B2
Authority
DE
Germany
Prior art keywords
formula
tert
choh
compounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1967B0093025
Other languages
German (de)
English (en)
Other versions
DE1593782A1 (de
Inventor
Herbert Dr.; Zeile Karl Prof. Dr.; 6507 Ingelheim; Engelhardt Albrecht Dr. 6500 Mainz Koppe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL136601D priority Critical patent/NL136601C/xx
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Priority to DE1967B0093025 priority patent/DE1593782B2/de
Priority to FR1583559D priority patent/FR1583559A/fr
Priority to US700376A priority patent/US3541130A/en
Priority to JP43038048A priority patent/JPS51100B1/ja
Priority to ES354823A priority patent/ES354823A1/es
Priority to NL6808196A priority patent/NL6808196A/xx
Priority to YU135068A priority patent/YU33262B/xx
Priority to CH1168170A priority patent/CH509973A/de
Priority to CH876668A priority patent/CH495950A/de
Priority to CH1167670A priority patent/CH509254A/de
Priority to CH1167970A priority patent/CH509257A/de
Priority to CH1167870A priority patent/CH509256A/de
Priority to CH1167770A priority patent/CH509255A/de
Priority to SE07980/68A priority patent/SE355571B/xx
Priority to CH1167570A priority patent/CH509253A/de
Priority to AT247770A priority patent/AT289076B/de
Priority to FI681664A priority patent/FI48922C/sv
Priority to AT247870A priority patent/AT289077B/de
Priority to IE710/68A priority patent/IE32373B1/xx
Priority to BE716647D priority patent/BE716647A/xx
Priority to AT572568A priority patent/AT289067B/de
Priority to AT248370A priority patent/AT289082B/de
Priority to AT248170A priority patent/AT289080B/de
Priority to AT248070A priority patent/AT289079B/de
Priority to DK281968AA priority patent/DK127059B/da
Priority to IL6830181A priority patent/IL30181A/xx
Priority to AT248270A priority patent/AT289081B/de
Priority to GB28529/68A priority patent/GB1187546A/en
Priority to AT247970A priority patent/AT289078B/de
Priority to BG011629A priority patent/BG15039A3/bg
Priority to BG011631A priority patent/BG15041A3/bg
Priority to BG011627A priority patent/BG15037A3/bg
Priority to BG011632A priority patent/BG15042A3/bg
Priority to BG011628A priority patent/BG15038A3/bg
Priority to BG011630A priority patent/BG15040A3/bg
Priority to FR166464A priority patent/FR8162M/fr
Priority to ES368398A priority patent/ES368398A1/es
Priority to ES368395A priority patent/ES368395A1/es
Priority to ES368401A priority patent/ES368401A1/es
Priority to ES368399A priority patent/ES368399A1/es
Priority to ES69368396A priority patent/ES368396A1/es
Priority to GB3825170A priority patent/GB1318533A/en
Priority to NL7111854.A priority patent/NL158171B/xx
Publication of DE1593782A1 publication Critical patent/DE1593782A1/de
Priority to US408743A priority patent/US3868460A/en
Priority to MY1973288A priority patent/MY7300288A/xx
Priority to YU2289/74A priority patent/YU33776B/xx
Priority to YU2288/74A priority patent/YU33775B/xx
Priority to YU2291/74A priority patent/YU33778B/xx
Priority to YU2292/74A priority patent/YU33779B/xx
Priority to YU2293/74A priority patent/YU35578B/xx
Priority to YU2294/74A priority patent/YU33780B/xx
Priority to YU2290/74A priority patent/YU33777B/xx
Priority to US05/502,634 priority patent/US3940489A/en
Priority to JP49119881A priority patent/JPS5112613B1/ja
Priority to US05/564,308 priority patent/US3961071A/en
Priority to US05/571,790 priority patent/US4039685A/en
Priority to US05/656,000 priority patent/US4036988A/en
Publication of DE1593782B2 publication Critical patent/DE1593782B2/de
Priority to IT7949447A priority patent/IT7949447A0/it
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1967B0093025 1967-02-06 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate Granted DE1593782B2 (de)

Priority Applications (59)

Application Number Priority Date Filing Date Title
NL136601D NL136601C (sv) 1967-06-15
DE1967B0093025 DE1593782B2 (de) 1967-06-15 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
FR1583559D FR1583559A (sv) 1967-06-15 1967-06-17
US700376A US3541130A (en) 1967-02-06 1968-01-25 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
JP43038048A JPS51100B1 (sv) 1967-06-15 1968-06-05
ES354823A ES354823A1 (es) 1967-06-15 1968-06-08 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3-ter-butilamino propanos sustituidos.
NL6808196A NL6808196A (sv) 1967-06-15 1968-06-11
YU135068A YU33262B (en) 1967-06-15 1968-06-12 Postopek za pripravo novih substiturnih 1-fenoksi -2-hidroksi-3-terc. butilamino-propanov
CH1168170A CH509973A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH876668A CH495950A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH1167670A CH509254A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH1167970A CH509257A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH1167870A CH509256A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH1167770A CH509255A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
SE07980/68A SE355571B (sv) 1967-06-15 1968-06-13
CH1167570A CH509253A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
AT247770A AT289076B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
FI681664A FI48922C (sv) 1967-06-15 1968-06-14 Förfarande för framställning av farmaceutiskt verksamma nya, både rase miska och optiskt aktiva substituerade 1-fenoxi-2-hydroxi-3-tert.butyl aminopropaner och dessa salter.
AT247870A AT289077B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
IE710/68A IE32373B1 (en) 1967-06-15 1968-06-14 Propanolamine derivatives
BE716647D BE716647A (sv) 1967-06-15 1968-06-14
AT572568A AT289067B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
AT248370A AT289082B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
AT248170A AT289080B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
AT248070A AT289079B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy-oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
DK281968AA DK127059B (da) 1967-06-15 1968-06-14 Analogifremgangsmåde til fremstilling af substituerede 1-phenoxy-2-hydroxy-3-tert.butylaminopropaner eller salte heraf eller de tilsvarende optisk aktive antipoder.
IL6830181A IL30181A (en) 1967-06-15 1968-06-14 1-(substituted phenoxy)-2-hydroxy-3-tertiary butylaminopropanes,their preparation and pharmaceutical compositions containing them
AT248270A AT289081B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
GB28529/68A GB1187546A (en) 1967-06-15 1968-06-14 Propanolamine derivatives
AT247970A AT289078B (de) 1967-06-15 1968-06-14 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
BG011629A BG15039A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови заместени 1-фенокси-2-хидрокси- -3-терц.бутиламинопропани и техните соли
BG011631A BG15041A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови заместени 1-фенокси 2-хидрокси-3-терц. бутиламино-пропани и техните соли
BG011627A BG15037A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови заместени 1-фенокси-2-хидрокси- -3-терц. бутиламинопропани и техните соли
BG011632A BG15042A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови-заместени 1-фенокси-2-хидрокси-3-терц. бутиламино пропани и техните соли
BG011628A BG15038A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови заместени 1-фенокси -2- хидрокси -3- терц.бутиламинопропани и техните соли
BG011630A BG15040A3 (bg) 1967-06-15 1968-06-15 Метод за получаване на нови заместени 1-фенокси-2-хидрокси -3-терц.бутиламинопропани и техните соли
FR166464A FR8162M (sv) 1967-06-15 1968-09-17
ES368398A ES368398A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368395A ES368395A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368401A ES368401A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368399A ES368399A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos.
ES69368396A ES368396A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
GB3825170A GB1318533A (en) 1967-06-15 1970-08-07 3-2-cyanophenoxy-2-hydroxy-n-ethyl-propylamine
NL7111854.A NL158171B (nl) 1967-06-15 1971-08-27 Werkwijze voor het op op zichzelf bekende wijze bereiden van een 1-(2- propargyloxyfenoxy) 3-alkylamino 2-propanol, werkwijze voor het bereiden van preparaten die deze verbinding bevatten, alsmede de verkregen gevormde preparaten.
US408743A US3868460A (en) 1967-02-06 1973-10-23 Therapeutic compositions and method
MY1973288A MY7300288A (en) 1967-06-15 1973-12-31 Propanolamine derivatives
YU2289/74A YU33776B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
YU2288/74A YU33775B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
YU2291/74A YU33778B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
YU2292/74A YU33779B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
YU2293/74A YU35578B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert. butyl amino propanes
YU2294/74A YU33780B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
YU2290/74A YU33777B (en) 1967-06-15 1974-08-21 Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
US05/502,634 US3940489A (en) 1967-02-06 1974-09-03 Therapeutic compositions and method
JP49119881A JPS5112613B1 (sv) 1967-06-15 1974-10-17
US05/564,308 US3961071A (en) 1967-02-06 1975-04-02 Therapeutic compositions and method
US05/571,790 US4039685A (en) 1967-02-06 1975-04-25 1-phenoxy-2-hydroxy-3-tert.-butylamino propane antiarrhythmic compounds
US05/656,000 US4036988A (en) 1967-02-06 1976-02-06 Therapeutic compositions and method
IT7949447A IT7949447A0 (it) 1967-02-06 1979-06-18 1-cianofenossi-2-idrossi-3-terz.butilamminopropani loro sali eprocedimento di preparazione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (de) 1967-06-15 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
DE1593782A1 DE1593782A1 (de) 1972-04-20
DE1593782B2 true DE1593782B2 (de) 1976-09-09

Family

ID=6986720

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1967B0093025 Granted DE1593782B2 (de) 1967-02-06 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Country Status (17)

Country Link
JP (2) JPS51100B1 (sv)
AT (8) AT289077B (sv)
BE (1) BE716647A (sv)
BG (6) BG15039A3 (sv)
CH (1) CH495950A (sv)
DE (1) DE1593782B2 (sv)
DK (1) DK127059B (sv)
ES (6) ES354823A1 (sv)
FI (1) FI48922C (sv)
FR (2) FR1583559A (sv)
GB (1) GB1187546A (sv)
IE (1) IE32373B1 (sv)
IL (1) IL30181A (sv)
MY (1) MY7300288A (sv)
NL (2) NL6808196A (sv)
SE (1) SE355571B (sv)
YU (7) YU33780B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (sv) * 1981-01-30 1982-08-05
DE3744371A1 (de) * 1987-12-29 1989-07-13 Jacobs Suchard Ag Verpackung fuer suesswaren
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (sv) * 1962-12-11

Also Published As

Publication number Publication date
FI48922B (sv) 1974-10-31
IL30181A0 (en) 1968-08-22
ES368396A1 (es) 1971-05-01
ES368398A1 (es) 1971-05-01
JPS5112613B1 (sv) 1976-04-21
AT289079B (de) 1971-04-13
IE32373L (en) 1968-12-15
AT289082B (de) 1971-04-13
ES368395A1 (es) 1971-05-01
BG15038A3 (bg) 1975-06-10
NL136601C (sv)
YU33778B (en) 1978-05-15
YU33779B (en) 1978-05-15
DE1593782A1 (de) 1972-04-20
YU229074A (en) 1977-10-31
MY7300288A (en) 1973-12-31
YU33775B (en) 1978-05-15
NL6808196A (sv) 1968-12-16
IE32373B1 (en) 1973-07-11
IL30181A (en) 1972-01-27
JPS51100B1 (sv) 1976-01-05
YU35578B (en) 1981-04-30
BG15039A3 (bg) 1975-12-15
YU33780B (en) 1978-05-15
AT289081B (de) 1971-04-13
AT289076B (de) 1971-04-13
BG15037A3 (bg) 1975-12-12
BG15041A3 (bg) 1975-10-22
SE355571B (sv) 1973-04-30
BG15040A3 (bg) 1975-10-25
BE716647A (sv) 1968-12-16
FI48922C (sv) 1975-02-10
FR8162M (sv) 1970-08-24
YU228974A (en) 1977-10-31
YU228874A (en) 1977-10-31
CH495950A (de) 1970-09-15
YU33776B (en) 1978-05-15
FR1583559A (sv) 1969-11-14
AT289077B (de) 1971-04-13
YU33777B (en) 1978-05-15
YU229474A (en) 1977-10-31
ES368399A1 (es) 1971-05-01
AT289080B (de) 1971-04-13
GB1187546A (en) 1970-04-08
YU229374A (en) 1980-09-25
BG15042A3 (bg) 1975-10-20
ES354823A1 (es) 1970-02-16
AT289067B (de) 1971-04-13
YU229174A (en) 1977-10-31
YU229274A (en) 1977-10-31
DK127059B (da) 1973-09-17
ES368401A1 (es) 1971-05-01
AT289078B (de) 1971-04-13

Similar Documents

Publication Publication Date Title
DE2615406A1 (de) Beta-adrenergische rezeptoren-blocker
EP0030380A1 (de) 2,3-Indoldionderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte, Arzneimittel enthaltend solche 2,3-Indoldionderivate und ihre pharmazeutische Verwendung
DE1593782B2 (de) 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0155518B1 (de) S(-)-Celiprolol, dessen pharmazeutisch verträgliche Salze, Verfahren zu deren Herstellung und pharmazeutische Zubereitung
AT391866B (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
DE1593782C3 (de) 1-Nitrilophenoxy- 2- hydroxy -3- tertbutylaminopropane, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE1593762A1 (de) Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
DE2914166A1 (de) Arylsubstituierte furane und verfahren zu ihrer herstellung
EP0037062B1 (de) Substituierte 3-Aryl-2-cycloalken-1-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE1543391C3 (de) 1-(2-Nitrilophenoxy)-2-hydroxy-3isopropylaminopropan und dessen Salze
DE2126169C3 (de) Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen
DE1950351C3 (de) l-(2-Cyano-5-methylphenoxy)-2-hydroxy-3-aIkylaminopropane, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2617967C3 (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
DE959097C (de) Verfahren zur Herstellung von basisch substituierten Diarylacetonitrilen
AT346838B (de) Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
AT289068B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen sowie von deren Säureadditionssalzen
DE1643237C3 (de) Kernsubstituierte 1-Nitrilophenoxy-3-tert.-butylamino-2-propanole, Verfahren zu deren Herstellung und pharmazeutische Präparate auf deren Basis
AT282596B (de) Verfahren zur herstellung von neuen, gemischt substituierten 1-phenoxy-3-alkylaminopropanolen-(2) und deren saeureadditionssalzen
AT290503B (de) Verfahren zur Herstellung von neuen 1-(4'-Acylaminophenoxy)-2-hydroxy-3-aminopropanen und von deren Säureadditionssalzen
AT258280B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
AT297681B (de) Verfahren zur Herstellung von neuen äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-butylaminopropanen, deren optisch aktiven Isomeren und Säureadditionssalzen
DE1593901C3 (de) Basisch substituierte Benzofurane oder Indole und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1668964A1 (de) Neue Trimethylhydrochinonderivate und Verfahren zur Herstellung derselben
DE2135711A1 (sv)
DE1618160A1 (de) AEthinylsubstituierte 1-Phenoxy-2-hydroxy-3-alkylaminopropane und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977